Resmed RMD
NYSE RMD
$252.82 -0.24 (-0.09%)
As of: Oct 23, 2026 · 3:59 PM EDT

Resmed (RMD) Gains from Sales and Divestitures (2014)

Updated

Resmed (RMD) reported Gains from Sales and Divestitures of $709,000 for FY2015 (year ended Jun 30, 2015).

Analysis

Resmed (RMD) Gains from Sales and Divestitures (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Resmed 36.86 Bn 30.93 Bn 861.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2014 709,000.00
API Access

Resmed Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=RMD&period=max&api_key=YOUR_API_KEY